Horowitz Limited Partnership VIII 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-10-30 5:00 pm Purchase |
2020-10-20 | 13D | Tarsus Pharmaceuticals, Inc. TARS |
Horowitz Limited Partnership VIII | 1,987,105 10.300% |
1,987,105 (New Position) |
Filing |